Search hospitals

>

Pennsylvania

>

Philadelphia

Temple University Hospital

Claim this profile

Philadelphia, Pennsylvania 19140

Global Leader in Lung Cancer

Global Leader in Chronic Obstructive Pulmonary Disease

Conducts research for Idiopathic Pulmonary Fibrosis

Conducts research for I Am A Healthy Volunteer

Conducts research for Coronavirus

392 reported clinical trials

58 medical researchers

Photo of Temple University Hospital in PhiladelphiaPhoto of Temple University Hospital in PhiladelphiaPhoto of Temple University Hospital in Philadelphia

Summary

Temple University Hospital is a medical facility located in Philadelphia, Pennsylvania. This center is recognized for care of Lung Cancer, Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis, I Am A Healthy Volunteer, Coronavirus and other specialties. Temple University Hospital is involved with conducting 392 clinical trials across 884 conditions. There are 58 research doctors associated with this hospital, such as Gerard J Criner, Hossein Borghaei, Deric C. Savior, and Angela Jain, MD.

Area of expertise

1

Lung Cancer

Global Leader

Temple University Hospital has run 41 trials for Lung Cancer. Some of their research focus areas include:

Stage IV
Stage III
Stage II
2

Chronic Obstructive Pulmonary Disease

Global Leader

Temple University Hospital has run 39 trials for Chronic Obstructive Pulmonary Disease. Some of their research focus areas include:

AAT
Stage II
Stage III

Top PIs

Clinical Trials running at Temple University Hospital

Lung Cancer

Stroke

Prostate Cancer

Non-Small Cell Lung Cancer

Chronic Obstructive Pulmonary Disease

Oropharyngeal Carcinoma

Pulmonary Hypertension

Gastroparesis

Cancer

Throat Cancer

Image of trial facility.

Immunotherapy + Chemotherapy

for Non-Small Cell Lung Cancer

This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.

Recruiting

2 awards

Phase 3

27 criteria

Image of trial facility.

High-Dose Radiation + Chemotherapy and Immunotherapy

for Non-Small Cell Lung Cancer

This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.

Recruiting

2 awards

Phase 3

14 criteria

Image of trial facility.

Osimertinib

for Non-Small Cell Lung Cancer

This phase II trial studies how well osimertinib works in treating patients with non-small cell lung cancer with EGFR exon 20 insertion mutation that is stage IIIB-IV or has come back after a period of improvement (recurrent). Osimertinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Recruiting

1 award

Phase 2

42 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Temple University Hospital?

Where is Temple University Hospital located?

Who should I call to ask about financial aid or insurance network?

What insurance does Temple University Hospital accept?

What awards or recognition has Temple University Hospital received?